X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. AJANTA PHARMA FDC LTD./
AJANTA PHARMA
 
P/E (TTM) x 26.3 20.6 127.7% View Chart
P/BV x 5.2 4.7 110.7% View Chart
Dividend Yield % 0.9 0.0 -  

Financials

 FDC LTD.   AJANTA PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
AJANTA PHARMA
Mar-18
FDC LTD./
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs1441,818 7.9%   
Low Rs791,106 7.1%   
Sales per share (Unadj.) Rs47.6239.5 19.9%  
Earnings per share (Unadj.) Rs7.652.8 14.4%  
Cash flow per share (Unadj.) Rs9.059.5 15.1%  
Dividends per share (Unadj.) Rs2.250-  
Dividend yield (eoy) %2.00-  
Book value per share (Unadj.) Rs47.5230.0 20.7%  
Shares outstanding (eoy) m177.8388.77 200.3%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.36.1 38.3%   
Avg P/E ratio x14.627.7 52.8%  
P/CF ratio (eoy) x12.324.6 50.3%  
Price / Book Value ratio x2.36.4 36.8%  
Dividend payout %29.60-   
Avg Mkt Cap Rs m19,784129,782 15.2%   
No. of employees `000NA6.8 0.0%   
Total wages/salary Rs m1,2213,765 32.4%   
Avg. sales/employee Rs ThNM3,128.4-  
Avg. wages/employee Rs ThNM554.0-  
Avg. net profit/employee Rs ThNM689.7-  
INCOME DATA
Net Sales Rs m8,45921,258 39.8%  
Other income Rs m394242 162.9%   
Total revenues Rs m8,85221,499 41.2%   
Gross profit Rs m2,0706,584 31.4%  
Depreciation Rs m249596 41.8%   
Interest Rs m314 756.3%   
Profit before tax Rs m2,1846,226 35.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6061,539 39.3%   
Profit after tax Rs m1,3534,686 28.9%  
Gross profit margin %24.531.0 79.0%  
Effective tax rate %27.724.7 112.2%   
Net profit margin %16.022.0 72.6%  
BALANCE SHEET DATA
Current assets Rs m4,35512,236 35.6%   
Current liabilities Rs m1,7923,461 51.8%   
Net working cap to sales %30.341.3 73.4%  
Current ratio x2.43.5 68.7%  
Inventory Days Days4460 73.8%  
Debtors Days Days2584 29.2%  
Net fixed assets Rs m3,02511,140 27.2%   
Share capital Rs m179177 101.0%   
"Free" reserves Rs m8,24320,237 40.7%   
Net worth Rs m8,45320,414 41.4%   
Long term debt Rs m1110 105.9%   
Total assets Rs m10,55724,486 43.1%  
Interest coverage x71.41,519.4 4.7%   
Debt to equity ratio x00 255.8%  
Sales to assets ratio x0.80.9 92.3%   
Return on assets %13.119.2 68.4%  
Return on equity %16.023.0 69.7%  
Return on capital %23.530.5 77.1%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Exports (fob) Rs m1,126NA-   
Imports (cif) Rs m283NA-   
Fx inflow Rs m1,14611,667 9.8%   
Fx outflow Rs m3551,616 22.0%   
Net fx Rs m79110,052 7.9%   
CASH FLOW
From Operations Rs m1,4852,854 52.0%  
From Investments Rs m-620-2,604 23.8%  
From Financial Activity Rs m-753-2 37,625.0%  
Net Cashflow Rs m113248 45.5%  

Share Holding

Indian Promoters % 68.9 73.8 93.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 1.6 303.2%  
FIIs % 7.5 7.6 98.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 17.0 111.8%  
Shareholders   23,730 20,968 113.2%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   MERCK LTD  CIPLA  TORRENT PHARMA  SUVEN LIFE  WYETH LTD  

Compare FDC LTD. With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Lower; Vedanta & Kotak Mahindra Top Losers(Closing)

Indian share markets ended marginally lower on Monday amid weak global cues. The BSE Metal index, however, lost 1.7 amid rising global trade war fears.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

After Vakrangee and Manpasand, More Auditors May Soon Resign. To Protect Your Wealth, Avoid these Stocks(The 5 Minute Wrapup)

Jun 8, 2018

The change in auditing regulations can bring a big change in corporate governance behaviour in the mid and small-cap space.

Should You Get out of Small Caps Now... Before the Fall Worsens(Profit Hunter)

Jun 6, 2018

An almost zero-loss strategy that works best when markets correct. Don't let the current volatility overwhelm you. Focus on the fundamentals and long term, and buy stocks where quality meets value.

Why Bank-Mergers Continue to Remain a Bad Idea(Vivek Kaul's Diary)

Jun 5, 2018

A newsreport suggests that the government plans to merge four public sector banks. We think it's a bad idea.

Has the Market Bottomed Out?(Sector Info)

Jun 11, 2018

The yield spread is an effective barometer that can indicate the direction the markets are headed.

Is Data Pointing Towards a Revival in the FMCG Sector?(Sector Info)

Jun 8, 2018

After several quarters of stress in the aftermath of demonetisation and the rollout of GST, this data is pointing towards revival in the India's rural FMCG industry.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Jun 18, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. 8-QTR ANALYSIS

COMPARE FDC LTD. WITH

MARKET STATS